Author:
Lin Guangxiao,Zhu Shenglong,Wu Yikuan,Song Ci,Wang Wanjing,Zhang Yuan,Chen Yue-Lei,He Zhao
Publisher
Springer Science and Business Media LLC
Reference54 articles.
1. Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000).
2. Block, G. E. Endocrine treatment of advanced mammary cancer. GP 20, 85–96 (1959).
3. De Marchi, T., Foekens, J. A., Umar, A. & Martens, J. W. Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer. Drug Discov Today 21, 1181–1188 (2016).
4. Musgrove, E. A. & Sutherland, R. L. Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 9, 631–643 (2009).
5. Collignon, J., Lousberg, L., Schroeder, H. & Jerusalem, G. Triple-negative breast cancer: treatment challenges and solutions. Breast Cancer (Dove Med Press) 8, 93–107 (2016).